Healthcare provider profile · identity verified

Brooks Betts, DO

Family Practice · THE VILLAGES, FL · NPI 1982653325

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	934	276
Losartan Potassium	Losartan Potassium	628	191
Amlodipine Besylate	Amlodipine Besylate	586	185
Rosuvastatin Calcium	Rosuvastatin Calcium	573	177
Levothyroxine Sodium	Levothyroxine Sodium	526	150
Pantoprazole Sodium	Pantoprazole Sodium	298	94
Lisinopril	Lisinopril	297	92
Metoprolol Succinate	Metoprolol Succinate	277	88
Metoprolol Tartrate	Metoprolol Tartrate	277	90
Valsartan	Valsartan	266	87
Tamsulosin Hcl	Tamsulosin Hcl	247	81
Simvastatin	Simvastatin	234	69
Hydrochlorothiazide	Hydrochlorothiazide	221	67
Omeprazole	Omeprazole	211	72
Eliquis	Apixaban	208	54
Pravastatin Sodium	Pravastatin Sodium	199	64
Metformin Hcl	Metformin Hcl	187	58
Gabapentin	Gabapentin	169	55
Allopurinol	Allopurinol	160	44
Torsemide	Torsemide	141	44
Fluticasone Propionate	Fluticasone Propionate	135	58
Escitalopram Oxalate	Escitalopram Oxalate	133	43
Finasteride	Finasteride	116	32
Ezetimibe	Ezetimibe	115	37
Sildenafil Citrate	Sildenafil Citrate	103	42
Donepezil Hcl	Donepezil Hcl	77	21
Fenofibrate	Fenofibrate	76	24
Sertraline Hcl	Sertraline Hcl	76	28
Clopidogrel	Clopidogrel Bisulfate	75	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	75	23
Famotidine	Famotidine	74	34
Alprazolam	Alprazolam	70	28
Citalopram Hbr	Citalopram Hydrobromide	64	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	21
Trazodone Hcl	Trazodone Hcl	63	27
Carvedilol	Carvedilol	60	22
Atenolol	Atenolol	58	18
Potassium Chloride	Potassium Chloride	55	22
Farxiga	Dapagliflozin Propanediol	53	18
Terazosin Hcl	Terazosin Hcl	51	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	17
Doxazosin Mesylate	Doxazosin Mesylate	49	14
Warfarin Sodium	Warfarin Sodium	49	12
Montelukast Sodium	Montelukast Sodium	47	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	16
Januvia	Sitagliptin Phosphate	42	18
Furosemide	Furosemide	41	17
Glimepiride	Glimepiride	40	12
Propranolol Hcl	Propranolol Hcl	40	12
Bupropion Xl	Bupropion Hcl	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	12
Zolpidem Tartrate	Zolpidem Tartrate	35	11
Clonidine Hcl	Clonidine Hcl	33	12
Estradiol	Estradiol	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	19
Albuterol Sulfate Hfa	Albuterol Sulfate	30	23
Alendronate Sodium	Alendronate Sodium	30	suppressed
Repatha Sureclick	Evolocumab	30	suppressed
Folic Acid	Folic Acid	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	24
Chlorthalidone	Chlorthalidone	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	19
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Irbesartan	Irbesartan	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Azithromycin	Azithromycin	22	20
Candesartan Cilexetil	Candesartan Cilexetil	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Amoxicillin	Amoxicillin	20	15
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Repaglinide	Repaglinide	20	suppressed
Meloxicam	Meloxicam	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Flecainide Acetate	Flecainide Acetate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Prednisone	Prednisone	17	suppressed
Ramipril	Ramipril	17	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	16	16
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Digoxin	Digoxin	16	suppressed
Ozempic	Semaglutide	16	suppressed
Cefuroxime	Cefuroxime Axetil	15	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	14
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Diazepam	Diazepam	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Sulindac	Sulindac	14	12
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Mercaptopurine	Mercaptopurine	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error